Abbott Laboratories (ABT)
(Delayed Data from NYSE)
$107.26 USD
+3.34 (3.21%)
Updated Jul 24, 2024 04:00 PM ET
Pre-Market: $107.03 -0.23 (-0.21%) 9:26 AM ET
2-Buy of 5 2
C Value C Growth D Momentum C VGM
Price, Consensus and EPS Surprise
ABT 107.26 +3.34(3.21%)
Will ABT be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ABT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ABT
Edwards Lifesciences (EW) Q2 Earnings Meet Mark, Margins Crash
Chemed (CHE) Q2 Earnings Miss Estimates, Margins Expand
ABT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Top Analyst Reports for SAP, Abbott Laboratories & Citigroup
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Quest Diagnostics (DGX) Tops Q2 Earnings, Raises 2024 Outlook
Other News for ABT
Unlocking Intrinsic Value: Analysis of Abbott Laboratories
7 Trustworthy Dividend Stocks to Steadily Build Your Portfolio
Abbott Laboratories Breaks Above 200-Day Moving Average - Bullish for ABT
LeMaitre Vascular: A Small Cap With Best-In-Industry Growth
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Elevance Health (ELV), CVS Health (CVS) and Abbott Laboratories (ABT)